Accutane and Roaccutane are being linked to at least 14 deaths this year–mainly from suicide. An inquiry in the UK has been opened after consumers shared adverse experiences to include young men who claim to have been left impotent & families whose children died from what they believe to be prescription-drug-induced suicides.

Get the full story here.

Study finds benzodiazepine prescriptions doubled during a 12-year period with more doctors prescribing them for conditions other than insomnia and anxiety.

“The problem is in the long term, they lead to more problems than they solve,” said Dr. Anna Lembke, Medical Director of addiction medicine at Stanford University. “People develop a tolerance, and they need more and more to get the same effect. They develop a dependence, finding when they don’t take them their anxiety is worse. And they think, ‘Oh, I need it because I have an anxiety disorder,’ but in many instances they’re actually medicating withdrawal from the last dose, so you can get into this vicious cycle.”

Read the full story here.

In episode 4 of Akathisia Stories, we hear from international drug safety advocate, Kim Witczak, who discusses the akathisia-induced death of her late husband, Woody, and her subsequent advocacy.

“Woody took the three-week sample pack, did what the doctor said – you know, take week one, week two,” says Kim, who was out of the country on a business trip when Woody started taking Zoloft as prescribed. When Kim came home, she saw Woody drenched with sweat. “He dropped his briefcase at the backdoor; went into a fetal position on our kitchen floor with his hands wrapped around his head like a vice, going: ‘Help me, Kim; help me. I don’t know what’s happening to me. It’s like my head’s outside my body looking in.’”

Listen to the full story here.

A large European study finds that more than 50% of patients who are prescribed drugs marketed as antidepressants do not receive enough information about the purpose of the treatments they are prescribed.  Nearly 80% of patients are also given no explanation about the drugs’ potential adverse effects.

Get the full story here.

Producer Andy Miles features an Akathisia Stories podcast extra: Drug safety advocate Kim Witczak discusses the birth of MISSD, her experiences on the FDA advisory panel, and how making akathisia a household word can reduce suffering and save lives. Listen here.

Zoloft is not effective in treating depressive symptoms, finds 6-week study. Pfizer Pharmaceuticals are the makers of Zoloft, the marketing name for sertraline. Read the full story here.

The fourth episode of our Akathisia Stories podcast features Kim Witczack who discusses her late husband, Woody, and his akathisia-induced death. Kim’s tireless advocacy began years ago when she filed a lawsuit against Zoloft maker, Pfizer Pharmaceuticals. Today Kim serves on many boards and is a consumer representative on the FDA Psychopharmacologic Drug Advisory Committee.

Listen to the podcast here.

Read the transcript here.

Adverse effects from asthma drug include “nightmares, seeing grotesque things while awake & being gripped by suicidal urges after taking the drug, also known by the brand name Singulair.” Many were never warned of the risks & their adverse experiences were dismissed.

Read the full story here.

Adverse drug effects, patient safety and suicide prevention initiatives are increasingly in the news. Yet much of the public remains unaware of akathisia. Please help MISSD change that by using Twitter hashtag #AkathisiaMatters and sharing today’s news release.

Anyone. Anywhere. Any time.

Our free, 1-hour accredited course is designed for your schedule. Start the course today and finish at your own pace. Log in at https://missd.learnupon.com/users/sign_up

Together we can save lives by increasing akathisia awareness.